SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
SEOUL, South Korea, Jan. 19, 2026 /PRNewswire/ -- CNP Global Co., Ltd. is a specialized development and outsource manufacturing company that develops beverages for children...
SHANGHAI, Jan. 19, 2026 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today announced that it has...
SYDNEY, Jan. 19, 2026 /PRNewswire/ -- As the new year begins, many Australians are setting resolutions focused on health, balance and long-term wellbeing. While...
SYDNEY, Jan. 19, 2026 /PRNewswire/ -- Taptouch Software, an Australian-owned hospitality POS provider, today announced the launch of its embedded payment solution (Tap to...